---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291951435.md"
description: "Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential."
datetime: "2026-07-07T14:39:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291951435.md)
  - [en](https://longbridge.com/en/news/291951435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291951435.md)
---

# 

Dyadic International shares are trading higher after the company announced continued progress across multiple global health collaborations validating its proprietary C1 protein production platform potential.

### Related Stocks

- [DYAI.US](https://longbridge.com/en/quote/DYAI.US.md)

## Related News & Research

- [Francisco Trust trustee Thomas Emalfarb sells 95,392 Dyadic International common shares worth $124,823.82](https://longbridge.com/en/news/293798588.md)
- [Dyadic Announces Continued Listing on the Nasdaq Capital Market | DYAI Stock News](https://longbridge.com/en/news/293751523.md)
- [The Protein Gold Rush Is Here—So Why Are Protein Stocks Crashing?](https://longbridge.com/en/news/293848698.md)
- [Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign | NXTS Stock News](https://longbridge.com/en/news/294063569.md)
- [10:16 ETAnimal-Free Egg Protein Market to Reach USD 1,933.5 Million by 2036 Driven by Precision Fermentation and Avian Flu Resilience, FMI](https://longbridge.com/en/news/294080816.md)